VTE Readmission Risk After Complex Cancer Surgery
The risk of a venous thromboembolism-related hospital readmission is increased well beyond 30 days after complex cancer surgery, a cohort study shows.
Stay updated with breaking news from Presection. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
The risk of a venous thromboembolism-related hospital readmission is increased well beyond 30 days after complex cancer surgery, a cohort study shows.
In a small study, just over half (59%) of patients who had combination immunotherapy showed no sign of tumor on preoperative endoscopy.
A blood test that measures circulating tumor DNA can identify patients with colorectal cancer who may derive the most benefit from adjuvant chemotherapy.
Women who develop breast implant–associated anaplastic large-cell lymphoma can achieve good outcomes with chemotherapy plus brentuximab vedotin.
Glioblastomas can be identified as a result of an incidental MRI finding. A study of 234 patients found four tumors. The study was published as a preprint and has not yet been peer reviewed.